J9320 HCPCS Level II code: Injection, streptozocin, 1 gram
J9320 is the HCPCS code for “Injection, streptozocin, 1 gram” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9320Injection, streptozocin, 1 gram
Short description: Streptozocin injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J9320 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 1986
Where J9320 sits
- 1J codesDrugs administered other than orally
- 2Active code J9320Injection, streptozocin, 1 gram
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9320 mean?
J9320 is the HCPCS code for “Injection, streptozocin, 1 gram” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9320?
CMS lists J9320’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9320
All J codesJ9314Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mgJ9315Injection, romidepsin, 1 mgJ9316Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mgJ9317Injection, sacituzumab govitecan-hziy, 2.5 mgJ9318Injection, romidepsin, non-lyophilized, 0.1 mgJ9319Injection, romidepsin, lyophilized, 0.1 mgJ9321Injection, epcoritamab-bysp, 0.16 mgJ9322Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mgJ9323Injection, pemetrexed ditromethamine, 10 mgJ9324Injection, pemetrexed (pemrydi rtu), 10 mgJ9325Injection, talimogene laherparepvec, per 1 million plaque forming unitsJ9326Injection, telisotuzumab vedotin-tllv, 1 mg